SEC Form 4/A · accession 0001209191-15-063788
EAGLE PHARMACEUTICALS, INC. · EGRX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
This is an amendment (Form 4/A). It replaces an earlier filing for the same period.
Reporting owner
David Pernock
Director
Period of report
Apr 21, 2015
Accepted (ET)
Aug 4, 2015 · 6:31 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000827871
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F1,F2 | $59.31 | Apr 21, 2015 | A | 10,000 | A | — | Apr 20, 2025 | Common Stock | 10,000 | 10,000 | D |
Explanation of responses
- F1This amendment is being filed solely to correct the number of shares of the stock option, which due to an administrative error was reported as 15,000 on the original Form 4. The correct number of shares is 10,000.
- F2The option fully vests on April 21, 2016, subject to the reporting person's continuous service with the issuer as of the vesting date.